Dimension Capital II, L.P. has filed 1 SEC Form 4 filing across 1 company in the last 90 days — buying. Lifetime open-market purchases: $20.00M.
| Role | Director |
|---|
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-12 | ODTX | Odyssey Therapeutics, Inc. | P — Open-market purchase | 1.11M | $18.00 | $20.00M |
| 2026-05-12 | ODTX | Odyssey Therapeutics, Inc. | J — Other acquisition / disposition | 1.71M | — |
Dimension Capital II, L.P. is a corporate insider — currently tracked as Director of Odyssey Therapeutics, Inc. (ODTX). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 1 open-market purchases ($20.00M) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Dimension Capital II, L.P. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.